Irritable bowel syndrome: a management strategy
Irritable bowel syndrome: a management strategy
复制标题
DOI：
10.1053/bega.1999.0039
复制
发表时间：
1999-10-01
影响因子：
3.2
通讯作者：
Thompson, WG
中科院分区：
文献类型：
--
作者：
Thompson, WG
在制定肠易激综合征（IBS）患者的管理策略时，我们必须考虑到大量患有这种疾病的人，他们中的大多数人并没有为此咨询医生。此外，我们必须意识到那些这样做的人的隐藏议程。肠易激综合征的原因是未知的，因此治愈这种慢性复发性疾病是不可能的。此外，这种疾病的成本非常高，需要从治疗更严重的疾病中提取宝贵的资源。在本章中，我提出了一个管理策略的基础上，使用最少的测试，考虑病人的议程，使用饮食建议，战略性使用药物，只有在耐药的情况下，分级治疗反应和持续护理IBS的坚定诊断。没有具体的治疗方法。医生与病人的互动是最重要的，以减轻病人的恐惧和关注，帮助他们与心理社会的困难，并提供已知的关怀支持，以最大限度地提高任何治疗的“安慰剂”的效果。
In the development of a management strategy for irritable bowel syndrome (IBS) patients we must consider the great number of people with the condition, most of whom do not consult doctors for it. Furthermore, we must be aware of the hidden agenda of those that do. The cause of IBS is unknown, and consequently cure of this chronic recurrent condition is not likely. Moreover, the disorder is very costly, drawing precious resources from the care of more serious diseases. In this chapter I propose a management strategy based on a firm diagnosis of IBS using a minimum of tests, consideration of the patient's agenda, the use of dietary advice, the strategic use of drugs only in resistant cases, a graded therapeutic response and continuing care. There is no specific treatment. The doctor-patient interaction is most important to allay patients' fears and concerns, assist them with psychosocial difficulties, and provide the caring support known to maximize the 'placebo' effect of any treatment.